Skip to main content
Marc-Alexander Mahl at World Health Summit 2025

October 13, 2025

Marc-Alexander Mahl at World Health Summit 2025

Am Montag, 13. Oktober um 11 Uhr MESZ, wird Marc-Alexander Mahl, President Pharma, Nutrition and Sustainability bei Fresenius Kabi, an der Session "Navigating Disruption: Pharma Manufacturing Amid Al, Geopolitics, & Supply Risk" teilnehmen.

Next event

Ralf Kuhlen at World Health Summit 2025

October 12, 2025

Ralf Kuhlen at World Health Summit 2025

On Sunday, October 12, at 11 a.m. CEST, Ralf Kuhlen, Chief Medical Officer at Fresenius, will attend the session "Leveraging Evidence and Tools to Advance AMR Policy Implementation".

Next event

October 13

October 13, 2025
Brussels, Belgium

Roadshow Brussels

November 20

November 20, 2025
virtual

BofA – Second Edition of EU MedTech CEO Fireside Chat Series

October 09

October 09, 2025
Virtual

J.P. Morgan – European Healthcare CEO Conference Call Series 2025

November 10

November 10, 2025
Palm Beach Gardens, USA

UBS – Global Healthcare Conference

October 09

October 09, 2025
Dallas, USA

Roadshow Dallas

October 08

October 08, 2025
Houston, USA

Roadshow Houston

October 08

October 08, 2025
Austin, USA

Roadshow Austin

Fresenius Kabi, part of the global healthcare company Fresenius, announced today it has received two awards for supply and service excellence from Vizient®, the largest provider-driven healthcare performance improvement company in the U.S.  

The Supplier of the Year Awards recognize outstanding suppliers by category that support Vizient’s mission to strengthen providers’ delivery of better, more affordable care.  

“These awards from Vizient are an important acknowledgment of the company’s commitment to long-term, sustainable drug supply,” said Arun Verma, president, Fresenius Kabi USA and a member of the Executive Leadership Team at Fresenius Kabi AG. “The Vizient Supply Assurance award is especially gratifying as it recognizes our efforts to assure continuity of supply for essential medicines and technologies."

Subscribe to